Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 238Carcinoma, Non-Small-Cell Lung 205Prostatic Neoplasms 137Lung Neoplasms 96Stomach Neoplasms 85Head and Neck Neoplasms 58Squamous Cell Carcinoma of Head and Neck 57Neoplasms 42Neoplasm Metastasis 39Esophageal Neoplasms 36Ovarian Neoplasms 29Pancreatic Neoplasms 27Sarcoma 19Urinary Bladder Neoplasms 18Adenocarcinoma of Lung 18Carcinoma, Squamous Cell 17Triple Negative Breast Neoplasms 15Nasopharyngeal Carcinoma 14Adenocarcinoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma Of Esophagus 13Recurrence 12Inflammatory Breast Neoplasms 10Carcinoma, Transitional Cell 10Breast Neoplasms, Male 10Esophageal Squamous Cell Carcinoma 9Laryngeal Neoplasms 8Uterine Cervical Neoplasms 7Nasopharyngeal Neoplasms 7Leiomyosarcoma 7

Interventions

Paclitaxel 12Cisplatin 11Hyperthermic Intraperitoneal Chemotherapy 10Cytoreduction Surgical Procedures 9Oxaliplatin 8Fluorouracil 7Mitomycin 6Carboplatin 5Leucovorin 4Bevacizumab 4catumaxomab 3Doxorubicin 3Docetaxel 3sodium thiosulfate 2Indocyanine Green 2Drug Therapy 2Cetuximab 2volociximab 1vandetanib 1relacorilant 1pasireotide 1nilotinib 1farletuzumab 1epothilone B 1enzastaurin 1birinapant 1alvimopan 1Surgical Procedures, Operative 1Saline Waters 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Peritoneal Neoplasms × Docetaxel × Clear all
NCT04840264 2024-03-18

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
79 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01504256 2018-01-23

CatuNeo

AIO-Studien-gGmbH

Phase 2 Completed
42 enrolled
Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

University of Southern California

Phase 2 Completed
20 enrolled 8 charts
Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡